Madalina Maxim

Toronto Public Health

Papers

1

Total Citations

79

H-Index

1

About

Dr. Madalina Maxim is a leading figure in gynecologic research, with a primary focus on the diagnosis and management of adenomyosis. Her most impactful contribution to date is the landmark "Guideline No. 437: Diagnosis and Management of Adenomyosis" (2023), which has already garnered 79 citations, underscoring its rapid adoption as a clinical standard. This work synthesizes evidence-based approaches to a condition historically underdiagnosed, providing clear protocols for imaging, medical therapy, and surgical intervention. Dr. Maxim’s research has significantly advanced the understanding of adenomyosis pathophysiology, bridging gaps between clinical practice and patient outcomes. Her efforts have been instrumental in developing non-invasive diagnostic criteria, reducing reliance on hysterectomy for confirmation, and improving fertility preservation strategies. With a citation trajectory reflecting growing influence, Dr. Maxim continues to shape gynecologic care, offering clinicians and researchers a robust framework for tackling one of the most challenging uterine disorders. Her work stands as a testament to the power of rigorous guideline development in transforming patient care.

Research Focus

Key Achievements

1
H-Index
1
Papers
79
Total Citations
79
Avg Citations/Paper
🏆 Most Cited Paper
Guideline No. 437: Diagnosis and Management of Adenomyosis
79 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Toronto Public Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago